{"title":"Readalyzer as a Novel Approach in the Visual Biofeedback Treatment of Congenital Nystagmus: A Case Study","authors":"","doi":"10.31707/vdr2022.8.2.p81","DOIUrl":null,"url":null,"abstract":"BACKGROUND: The treatment of nystagmus remains a clinical enigma. While many non-surgical therapeutic options have been advanced, and tried with success, relatively few are typically offered to most patients.\nCASE STUDY: We present a multi-phase, detailed case study of an adult with congenital nystagmus, and later an acquired visual field defect, in which three distinct forms of vision-based, biofeedback therapy were incorporated: the primary one was a novel use\nof the Readalyzer eye movement system, in conjunction with conventional oculomotor-based visual scanning therapy and yoked prisms.\nCONCLUSION: After completion of the multi-phase treatment, the patient’s nystagmus reduced, and both visual acuity and ambulation improved. The present findings are consistent with earlier results, which suggested a multi-modal therapeutic approach in those with nystagmus.","PeriodicalId":148913,"journal":{"name":"Vision Development & Rehabilitation","volume":"26 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vision Development & Rehabilitation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31707/vdr2022.8.2.p81","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND: The treatment of nystagmus remains a clinical enigma. While many non-surgical therapeutic options have been advanced, and tried with success, relatively few are typically offered to most patients.
CASE STUDY: We present a multi-phase, detailed case study of an adult with congenital nystagmus, and later an acquired visual field defect, in which three distinct forms of vision-based, biofeedback therapy were incorporated: the primary one was a novel use
of the Readalyzer eye movement system, in conjunction with conventional oculomotor-based visual scanning therapy and yoked prisms.
CONCLUSION: After completion of the multi-phase treatment, the patient’s nystagmus reduced, and both visual acuity and ambulation improved. The present findings are consistent with earlier results, which suggested a multi-modal therapeutic approach in those with nystagmus.